Moderna shares plummet after Covid vaccine maker lowers 2022 sales outlook
Moderna also missed revenue and earnings expectations for the quarter. Source link
Read More
epidemics
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics
CEO Albert Bourla said Pfizer is staring down an expected loss of up to $18 billion in revenue from 2025
Read More
FDA says two studies showing omicron boosters weren’t much better than old Covid shots were too small to come to any conclusions
The FDA pushed back against two independent studies that found the new boosters don't trigger a better immune response than
Read More
Watch live: Biden to sign Inflation Reduction Act into law, setting 15% minimum corporate tax rate
After more than a year of debate, Biden's sweeping infrastructure bill is becoming law — albeit a significantly smaller version
Read More
Passage of Inflation Reduction Act gives Medicare historic new powers over drug prices
The legislation represents a historic expansion of Medicare's power that was fiercely opposed by the pharmaceutical industry. Source link
Read More
CDC eases Covid guidance as U.S. has more tools to fight the virus and keep people out of the hospital
The public health agency said the virus now poses a significantly lower risk due to high levels of immunity from
Read More
FDA expands monkeypox vaccine authorization to increase dose supply five-fold
FDA expands monkeypox vaccine authorization to increase dose supply five-fold Source link
Read More
Novavax cuts 2022 revenue guidance in half, stock tanks in after-hours trading
The Maryland biotech company cut its 2022 sales outlook by about 50% and now expects to generate $2 billion to
Read More
‘Stressed out’ STD clinics struggle to handle surge in monkeypox patients as U.S. outbreak grows
Sexual health clinics are facing a surge of patients seeking testing, vaccines and treatment for monkeypox. Source link
Read More